SiNuo New Drugs

PharmaceuticalsSeries ANanjing, China

Latest round

Series A

Last raised

Mar 2026

Total raised

Undisclosed

Investors

1

About SiNuo New Drugs

, dba SiNuo New Drugs, focuses on the research and development of radiopharmaceuticals, aiming to build integrated diagnostic-to-therapeutic drug solutions. SiNuo New Drugs specializes in radiopharmaceutical R&D, including targeted radioactive isotope-labeled drugs, supporting both diagnostic imaging and therapeutic applications, and provides integrated development from discovery to preclinical stages. The company’s revenue is generated from out-licensing of radiopharmaceutical drug candidates, collaborative R&D and co-development partnerships, and milestone-based payments related to diagnostic and therapeutic nuclear medicine programs.

Who invested in SiNuo New Drugs

1 investor across 1 round

See all investors in SiNuo New Drugs

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 3, 2026

    Amount

    Undisclosed

    Investors

    Locked

Questions about SiNuo New Drugs

Who invested in SiNuo New Drugs?

SiNuo New Drugs has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has SiNuo New Drugs raised?

SiNuo New Drugs has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did SiNuo New Drugs last raise money?

SiNuo New Drugs's most recent round on record is a Series A, in Mar 2026.

What does SiNuo New Drugs do?

, dba SiNuo New Drugs, focuses on the research and development of radiopharmaceuticals, aiming to build integrated diagnostic-to-therapeutic drug solutions.

Where is SiNuo New Drugs headquartered?

SiNuo New Drugs is headquartered in Nanjing, China.

Which VCs invest in companies like SiNuo New Drugs?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at SiNuo New Drugs's stage. Their profiles are linked below.

Raising like SiNuo New Drugs? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.